Your browser doesn't support javascript.
loading
CRISPR-Cas9 knockout screen identifies novel treatment targets in childhood high-grade glioma.
Wenger, Anna; Karlsson, Ida; Kling, Teresia; Carén, Helena.
Affiliation
  • Wenger A; Sahlgrenska Center for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 1F, 405 30, Gothenburg, Sweden.
  • Karlsson I; Sahlgrenska Center for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 1F, 405 30, Gothenburg, Sweden.
  • Kling T; Sahlgrenska Center for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 1F, 405 30, Gothenburg, Sweden.
  • Carén H; Sahlgrenska Center for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 1F, 405 30, Gothenburg, Sweden. helena.caren@gu.se.
Clin Epigenetics ; 15(1): 80, 2023 05 09.
Article de En | MEDLINE | ID: mdl-37161535
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Systèmes CRISPR-Cas / Gliome Limites: Child / Humans Langue: En Journal: Clin Epigenetics Année: 2023 Type de document: Article Pays d'affiliation: Suède
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Systèmes CRISPR-Cas / Gliome Limites: Child / Humans Langue: En Journal: Clin Epigenetics Année: 2023 Type de document: Article Pays d'affiliation: Suède